{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:49:57Z","timestamp":1770918597876,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bbadis.2018.10.027","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T04:01:24Z","timestamp":1540872084000},"page":"454-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["MLL3 enhances the transcription of PD-L1 and regulates anti-tumor immunity"],"prefix":"10.1016","volume":"1865","author":[{"given":"Wei","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanghao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changkun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengzhu","family":"Jian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.10.027_bb0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrm3949","article-title":"The selection and function of cell type-specific enhancers","volume":"16","author":"Heinz","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.molcel.2017.04.018","article-title":"Mll3 and Mll4 facilitate enhancer RNA synthesis and transcription from promoters independently of H3K4 monomethylation","volume":"66","author":"Dorighi","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2010.02.008","article-title":"Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages","volume":"32","author":"Ghisletti","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0020","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature07829","article-title":"Histone modifications at human enhancers reflect global cell-type-specific gene expression","volume":"459","author":"Heintzman","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nrc3929","article-title":"Hijacked in cancer: the KMT2 (MLL) family of methyltransferases","volume":"15","author":"Rao","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1097-2765(00)80028-3","article-title":"Recruitment of CBP\/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription","volume":"1","author":"Merika","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0040","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/MCB.01181-13","article-title":"The MLL3\/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers","volume":"33","author":"Hu","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0045","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0050","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86014","article-title":"T cell Bim levels reflect responses to anti-PD-1 cancer therapy","volume":"1","author":"Dronca","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-8722-6-74","article-title":"The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies","volume":"6","author":"Shi","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0060","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1111\/j.1600-6143.2012.04224.x","article-title":"Role of the PD-1 pathway in the immune response","volume":"12","author":"Riella","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0080","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/TP.0000000000000813","article-title":"Advances on non-CD4 + Foxp3+ T regulatory cells: CD8+, type 1, and double negative T regulatory cells in organ transplantation","volume":"99","author":"Ligocki","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0085","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1073\/pnas.1203479109","article-title":"Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.celrep.2016.03.038","article-title":"Activation of P-TEFb by androgen receptor-regulated enhancer RNAs in castration-resistant prostate cancer","volume":"15","author":"Zhao","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1097-2765(03)00492-1","article-title":"Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3\u2032 end processing","volume":"13","author":"Ahn","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/liv.13191","article-title":"Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area","volume":"37","author":"Im","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0105","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","article-title":"A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping","volume":"159","author":"Rao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0110","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ng.3286","article-title":"Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C","volume":"47","author":"Mifsud","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0115","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/ng.3935","article-title":"Lineage-specific dynamic and pre-established enhancer-promoter contacts cooperate in terminal differentiation","volume":"49","author":"Rubin","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0120","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/cr.2012.15","article-title":"Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization","volume":"22","author":"Chepelev","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0125","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tips.2015.06.005","article-title":"New immunotherapies targeting the PD-1 pathway","volume":"36","author":"Chinai","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13148-015-0075-3","article-title":"Somatic cancer mutations in the MLL3-SET domain alter the catalytic properties of the enzyme","volume":"7","author":"Weirich","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature15251","article-title":"Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth","volume":"525","author":"Zhu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0145","doi-asserted-by":"crossref","first-page":"38551","DOI":"10.18632\/oncotarget.9535","article-title":"Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2018.10.027_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-018-0758-7","article-title":"Role of metabolism in cancer cell radioresistance and radiosensitization methods","volume":"37","author":"Tang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0155","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm.4379","article-title":"Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation","volume":"23","author":"Zhang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2018.10.027_bb0160","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/nprot.2007.243","article-title":"Quantitative analysis of chromosome conformation capture assays (3C-qPCR)","volume":"2","author":"Hagege","year":"2007","journal-title":"Nat. Protoc."}],"updated-by":[{"DOI":"10.1016\/j.bbadis.2019.01.030","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000}}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918304307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918304307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:45:38Z","timestamp":1760417138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918304307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0925443918304307"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.027","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bbadis.2019.01.030","asserted-by":"object"}]},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MLL3 enhances the transcription of PD-L1 and regulates anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}